ProPhase Labs, Inc.
NASDAQ: PRPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ted William Karkus
- Employees
- 96
- Headquarters
- Garden City, United States
- IPO year
- 1994
- Market cap
- $452.9K
- Website
- https://www.prophaselabs.com
Loading PRPH…
Loading profile data…Frequently asked questions about PRPH
What does ProPhase Labs, Inc. (PRPH) do?
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developin...
Where does PRPH trade?
ProPhase Labs, Inc. (PRPH) trades on the NASDAQ Capital Market.
What sector is PRPH in?
ProPhase Labs, Inc. (PRPH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ProPhase Labs, Inc.?
Ted William Karkus is the chief executive officer of ProPhase Labs, Inc. (PRPH).
Where is ProPhase Labs, Inc. headquartered?
ProPhase Labs, Inc. is headquartered in United States.
Does PRPH pay a dividend?
ProPhase Labs, Inc. (PRPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRPH go public?
ProPhase Labs, Inc. (PRPH) completed its initial public offering in 1994.